Centenial Surgic — 360° view

Centenial Surgic, a company in the Medical Equipment & Supplies industry, reported revenue of ₹14 crore and net profit of ₹0.69 crore for the September 2026 quarter.

Centenial Surgic (BSE: CSURGSU) closed at ₹100.63 on 20 Nov 2026, down 0.7% over the past year. Its market capitalisation is ₹37 crore.

Share price
₹100.63 (20 Nov 2026)
Market cap
₹37 Cr (20 Nov 2026)
Revenue
₹14 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
2.45% (FY26)
ROE
-7.42% (FY26)
Book value
₹78.3 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹124.90 / ₹66.60 (20 Nov 2026)
1-year return
-0.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
BSE: CSURGSU

Incorporated in 1995, Centenial Surgical Suture is engaged in the development, manufacturing and supply of Medical Devices.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.